Famotidine
- Product NDC
- 25021-756
- 11-digit product format
- 250210756
- Labeler code
- 25021
- Product ID
- 25021-756_82835fd5-d117-4b63-82c2-fe5642fc04dd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Famotidine
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- NDA219935
- Marketing category
- NDA
- Marketing start
- 2025-10-15
- Marketing end
- 2027-03-31
- Substance
- FAMOTIDINE
- Active strength
- 4 mg/mL
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Famotidine
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FAMOTIDINE | 4 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5QZO15J2Z8 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 25021-756-10 | Famotidine | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | | 5 |
| 25021-756-10 | Famotidine | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | | 5 |
| 25021-756-50 | Famotidine | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 5 |
| 25021-756-50 | Famotidine | 50 mL in 1 VIAL | INJECTION, SOLUTION | 50 | | 5 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-756-10 | 25021075610 | 10 VIAL in 1 CARTON (25021-756-10) / 10 mL in 1 VIAL | 10 vial | 2025-10-15 | 2027-03-31 | No | No | Historical |
| 25021-756-50 | 25021075650 | 1 VIAL in 1 CARTON (25021-756-50) / 50 mL in 1 VIAL | 1 vial | 2025-10-15 | 2027-02-28 | No | No | Historical |